Janelle Davison, OD: Alcon: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Orasis: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Scope Eye Care: Consulting Fees (); Tarsus Pharma: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); twenty twenty beauty: Advisory Committee/Board Member (); Viatris: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); virtual visual field: Consulting Fees ()
Dry eye disease (DED) is no longer limited to older adults or those with autoimmune conditions. It now affects all age groups, with a strong connection to prolonged screen time on phones and computers. Digital device use disrupts tear stability and increases dry eye symptoms, making it a growing concern for younger generations. This course will highlight the risks across different age groups and provide practical strategies for effectively managing dry eye in younger patients.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Understand key risk factors in younger patients regarding the impact of digital device use, harmful beauty trends, and contact lens considerations on tear film stability and dry eye disease
Develop effective clinical protocols: Learn how to screen, diagnose, and manage dry eye disease in younger patients using evidence-based approaches and clinical pearls for success.
Implement advanced treatment strategies: Gain insights into in-office treatment options and strategies to optimize outcomes for younger patients with dry eye disease.
